To hear about similar clinical trials, please enter your email below
Trial Title:
Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation
NCT ID:
NCT05546892
Condition:
Colon Cancer
Conditions: Official terms:
Colonic Neoplasms
Conditions: Keywords:
colon cancer
MBP
bowel preparation
oral antibiotics
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Full bowel preparation prior to colon resection for cancer
Description:
Mechanical bowel preparation and oral antibiotics
Arm group label:
Full bowel preparation (MBP+OA)
Intervention type:
Procedure
Intervention name:
No bowel preparation
Description:
Omission of any bowel preparation
Arm group label:
No bowel preparation
Summary:
The purpose of the study is to determine if short-term outcomes of colon resections after
full bowel preparation (mechanical bowel preparation plus oral antibiotics) are superior
to colon resections with no bowel preparation.
Detailed description:
The design involves random allocation of eligible patients to full bowel preparation or
no bowel preparation in 1:1 ratio. After that colon resection is performed in both
groups.
Short-term outcomes are assessed in 30 day period after surgery. This is a superiority
trial evaluating statistical superiority. Rate of anastomotic leak is anticipated to
decrease from 8% (data from local registry) to 3%. For power of 80% enrolment of 586
patients is required.
The intent-to-treat principle is used for the data analysis.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- histologically confirmed adenocarcinoma of the colon (caecum, ascending, transverse,
descending, sigmoid)
- clinical stage T1-4aN0-2M0-1 (distant metastases must be resectable)
- indications for surgical colonic resection
- ECOG status 0-2
- At least 18 years of age
- Written informed consent
Exclusion Criteria:
- Medical or psychiatric conditions that compromise the patient's ability to give
informed consent or comply with the study protocol
- Pregnancy or breast feeding
- Medical contraindications for surgical treatment
- Any use of antibiotics 30 days prior to inclusion
- Functioning stoma
- Contraindications for use of MBP or OA drugs or their components
- Indications for mandatory MBP (planned intraoperative colonoscopy etc)
- Indications for obstructive resection
- Acute bowel obstruction, bleeding or perforation
- Other malignancies not in remission
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
N.N. Petrov National Medical Research Center of Oncology
Address:
City:
Saint Petersburg
Zip:
197758
Country:
Russian Federation
Status:
Recruiting
Contact:
Last name:
Aleksei Petrov
Phone:
+79214117866
Email:
alexpetrov@doctor.com
Investigator:
Last name:
Aleksei Karachun
Email:
Principal Investigator
Investigator:
Last name:
Aleksei Petrov
Email:
Sub-Investigator
Start date:
February 10, 2023
Completion date:
September 2025
Lead sponsor:
Agency:
N.N. Petrov National Medical Research Center of Oncology
Agency class:
Other
Source:
N.N. Petrov National Medical Research Center of Oncology
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05546892